Fingerprint
Dive into the research topics of 'Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically